Project Description
Hyperbaric Oxygen Therapy for Treating Cancer
In 2013, over 1.6 million people were diagnosed with cancer and over 500,000 cancer-related deaths occurred in the U.S. alone. Cancer is one of the leading causes of death world-wide, and new integrated treatments are being utilized to help combat its devastating effects. Hyperbaric oxygen therapy (HBOT) is currently being utilized in conjunction with conventional treatments, including radiation and chemotherapy, to attain optimal dosages for patients, stimulate tumor regression and reduce the side effects of treatments. Cancer thrives in hypoxic or low-oxygen environments and HBOT has been shown to increase these oxygen levels to weaken tumors and reduce their aggressiveness. Studies have demonstrated the benefits of HBOT for cancer with the following:
Enhances “Conventional” Cancer Therapies & Treatments
- Increases Oxygen Levels in Tumors
- Better Radiation Therapy Results
- Improves Chemotherapy Outcome
- Enhances Brain Treatment
- Decreases Tumor Drug Resistance
- Allows for Optimal Therapy Dosage to be Attained
- Improves Surgical Results
Reduces Tumor Aggressiveness
- Weakens Hypoxic Tumors
- Targets Metastatic Tumors
Increases Natural Killer Cell Activity and Function
- Increases Reactive Oxygen Species Production
- Amplifies Cancer Cell Death
- Regresses Tumor Volume
Reduces Side Effects of “Conventional” Cancer Therapies & Treatments
- Reduces Radiation Therapy Side Effects
- Decreases Chemotherapy Side Effects
- Accelerates Post-Operative Healing & Prevents Infection
- Reduces Chemo-Brain Syndrome Symptoms
Enhances IV Cancer Treatments
- Increases Intravenous Vitamin C Therapy Effect
Cancer Prevention
- Decreases Inflammatory Markers
- Normalizes Intracellular Oxygen Levels
- Stimulates Cellular Detoxification
- Reduces Risk of Pathogenic Inflammatory-Related Tumors
- Supports Cellular Energy Processes for Optimal DNA Repair